Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo)-Reference-Cited by-同舟云学术

Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo)

Published:2023-04 Issue: Volume:178 Page:191-197
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Vergnenegre Alain,Monnet Isabelle,Ricordel Charles,Bizieux Acya,Curcio Hubert,Bernardi Marie,Corre Romain,Guisier Florian,Hominal Stéphane,Le Garff Gwenaelle,Bylicki Olivier,Locher Chrystèle,Geier Margaux,Chouaïd Christos,Robinet Gilles

Funder

F. Hoffmann-La Roche Ltd

Pierre Fabre Médicament SAS

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

2. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018

3. Checkpoint inhibitors in lung cancer: latest developments and clinical potential;Schvartsman;Ther. Adv. Med. Oncol.,2016

4. Prospects and progress of atezolizumab in non-small cell lung cancer;Vansteenkiste;Expert Opin. Biol. Ther.,2017

5. Pharmacological management of relapsed/refractory NSCLC with chemical drugs;Karachaliou;Expert Opin. Pharmacother.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial;Nature Medicine;2024-07-05

2. Key Determinants of Immune-Mediated Adverse Reactions to Oncology Drugs;Cancers;2023-11-28

3. Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment;Journal of Drug Delivery Science and Technology;2023-11

4. A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer;Thoracic Cancer;2023-07-04